Literature DB >> 20359890

Structural requirement(s) of N-phenylthioureas and benzaldehyde thiosemicarbazones as inhibitors of melanogenesis in melanoma B 16 cells.

P Thanigaimalai1, Tuan Anh Le Hoang, Ki-Cheul Lee, Seong-Cheol Bang, Vinay K Sharma, Cheong-Yong Yun, Eunmiri Roh, Bang-Yeon Hwang, Youngsoo Kim, Sang-Hun Jung.   

Abstract

In order to define the structural requirements of phenylthiourea (PTU), a series of thiourea and thiosemicarbazone analogs were prepared and evaluated as inhibitors of melanogenesis in melanoma B16 cells. The most potent analog was 2-(4-tert-butylbenzylidene)hydrazinecarbothioamide (1u) with an IC(50) value of 2.7 microM in inhibition of melanogenesis. The structure for potent inhibitory activity of these derivatives are required with the direct connection of pi-planar structure to thiourea without steric hinderance in PTU derivatives and the hydrophobic substituent at para position in case of semicarbazones. 2010. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20359890     DOI: 10.1016/j.bmcl.2010.02.067

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  14 in total

1.  1-(2-Hy-droxy-eth-yl)-3-(3-meth-oxy-phen-yl)thio-urea.

Authors:  Hyeong Choi; Yong Suk Shim; Byung Hee Han; Sung Kwon Kang; Chang Keun Sung
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-09-04

2.  1-(4-Hy-droxy-phen-yl)-3-(3,4,5-tri-methoxy-phen-yl)thio-urea.

Authors:  Hyeong Choi; Byung Hee Han; Yong Suk Shim; Sung Kwon Kang; Chang Keun Sung
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-11-27

3.  N-(2,5-Dimeth-oxy-phen-yl)-N'-(4-hy-droxy-pheneth-yl)urea.

Authors:  Hyeong Choi; Byung Hee Han; Yong Suk Shim; Sung Kwon Kang; Chang Keun Sung
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-10-02

4.  1-(2,5-Dimeth-oxy-phen-yl)-3-(2-hy-droxy-eth-yl)urea.

Authors:  Hyeong Choi; Taewoo Lee; Byung Hee Han; Sung Kwon Kang; Chang Keun Sung
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-07-24

5.  N-(4-Hy-droxy-phen-yl)-3,4,5-trimeth-oxy-benzamide.

Authors:  Hyeong Choi; Yong Suk Shim; Byung Hee Han; Sung Kwon Kang; Chang Keun Sung
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-10-08

6.  2-(2,5-Dimeth-oxy-phen-yl)-N-[2-(4-hy-droxy-phen-yl)eth-yl]acetamide.

Authors:  Hyeong Choi; Yong Suk Shim; Byung Hee Han; Sung Kwon Kang; Chang Keun Sung
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-03-07

7.  N-(2,5-Dimeth-oxy-phen-yl)-N'-[4-(2-hy-droxy-eth-yl)phen-yl]urea.

Authors:  Hyeong Choi; Yong Suk Shim; Byung Hee Han; Sung Kwon Kang; Chang Keun Sung
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-08-25

Review 8.  Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitors.

Authors:  Thanigaimalai Pillaiyar; Manoj Manickam; Vigneshwaran Namasivayam
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

9.  Crystal structure of bis-(4-allyl-2-meth-oxy-phen-yl) terephthalate.

Authors:  Sung Kwon Kang; Byung Hee Han
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-09-30

10.  Vasculoprotective Effects of 3-Hydroxybenzaldehyde against VSMCs Proliferation and ECs Inflammation.

Authors:  Byung Soo Kong; Soo Jung Im; Yang Jong Lee; Yoon Hee Cho; Yu Ri Do; Jung Woo Byun; Cheol Ryong Ku; Eun Jig Lee
Journal:  PLoS One       Date:  2016-03-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.